Securisyn Medical
Patented interlocking medical devices prevent costly & deadly tube dislodgement
Overview
Raised: $112,484
Rolling Commitments ($USD)
12/31/2022
$1,875
181
2011
Healthcare & Pharmaceuticals
HealthTech
B2B
Medium
High
Summary Profit and Loss Statement
Most Recent Year | Prior Year | |
---|---|---|
Revenue |
$4,454 |
$1,188,538 |
COGS |
$0 |
$0 |
Tax |
$0 |
$0 |
| ||
| ||
Net Income |
$-1,261,856 |
$-2,380,266 |
Summary Balance Sheet
Most Recent Year | Prior Year | |
---|---|---|
Cash |
$369,852 |
$730,518 |
Accounts Receivable |
$4,618 |
$45,618 |
Total Assets |
$851,987 |
$1,088,727 |
Short-Term Debt |
$1,061,475 |
$2,330,940 |
Long-Term Debt |
$3,266,577 |
$978,487 |
Total Liabilities |
$4,328,052 |
$3,309,427 |
Upgrade to gain access
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Healthcare providers commonly use tape to secure breathing tubes used to keep ventilated patients alive. But tape is so unstable that unplanned extubation (the accidental removal of a breathing tube from an airway) is associated with 33,000 preventable deaths each year in the United States.
The technology is archaic. In fact, it’s a joke. Somehow, no company has stepped forward to offer a product that can prevent the epidemic of endotracheal tube slippage and unplanned extubation.
Until now.
The company I’m introducing to you today — Securisyn Medical — has patented a tube stabilization device that solves the life-threatening issues surrounding unplanned extubation and tube slippage.